Attached files
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. Sec.1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of MabVax Therapeutics
Holdings, Inc. (the Company) on Form 10-K for the year ended
December 31, 2017, as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, Gregory P. Hanson,
Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to my
knowledge:
|
|
1)
|
The Report fully complies with the requirements of
Section 13(a) or 15 (d) of the Securities Exchange Act of
1934; and
|
|
|
2)
|
The information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
April 2, 2018
|
/s/ Gregory P.
Hanson
|
|
Gregory P. Hanson
|
|
Chief Financial Officer
|
|
(Principal Financial Officer)
|
A signed original of this written statement required by
Section 906 of the Sarbanes-Oxley Act of 2002 has been
provided to MabVax Therapeutics Holdings, Inc. and will be
furnished to the Securities and Exchange Commission or its staff
upon request.